Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician  Philippe Moingeon, PhD  The Journal of.

Slides:



Advertisements
Similar presentations
Advances in Diagnosing Peanut Allergy
Advertisements

Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Immunotherapy for Food Allergy: Are We There Yet?
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
Regulatory T cells in allergic diseases
Advances in food allergy in 2015
Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance  Margot Berings, MD, Cagatay Karaaslan,
Gut matters: Microbe-host interactions in allergic diseases
Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences.
Making the Most of In Vitro Tests to Diagnose Food Allergy
Allergy prevention starts before conception: Maternofetal transfer of tolerance protects against the development of asthma  Tobias Polte, PhD, Christian.
Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.
Allergic sensitization can be induced via multiple physiologic routes in an adjuvant- dependent manner  David Dunkin, MD, M. Cecilia Berin, PhD, Lloyd.
Regulation of TH17 cells in the mucosal surfaces
Matthew C. Tunis, BSc, Wojciech Dawicki, PhD, Kaitlyn R
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Lung dendritic cells induce TH17 cells that produce TH2 cytokines, express GATA-3, and promote airway inflammation  Marianne Raymond, PhD, Vu Quang Van,
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Robert G. Hamilton, PhD, John Oppenheimer, MD 
Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant Bet v 1, the major birch pollen allergen,
Forkhead box protein 3 demethylation is associated with tolerance induction in peanut- induced intestinal allergy  Meiqin Wang, MD, PhD, Ivana V. Yang,
Oliver T. Burton, PhD, Jaciel M. Tamayo, PhD, Amanda J
Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model  Lucie Mondoulet, PhD, Vincent Dioszeghy, PhD, Emilie Puteaux,
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Mucosal Immunology of Food Allergy
Advances in Diagnosing Peanut Allergy
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Nonadherence to Asthma Treatment: Getting Unstuck
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
The Immunological Mysteries of Tuberculosis
Immunology of Food Allergy
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2  Phillip Lieberman, MD  The Journal of Allergy.
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Phillip Lieberman, MD, Michael Tankersley, MD 
Can we produce true tolerance in patients with food allergy?
The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells  Juha Punnonen, MD, PhD, Hans Yssel, PhD,
Phillip Lieberman, MD, David Golden, MD 
Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase  Phillip Lieberman, MD, Lawrence B. Schwartz, MD,
Linda S. Cox, MD, Cheryl Hankin, PhD, Richard Lockey, MD 
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
The role of the T cell in asthma
Cephalosporin Side Chain Cross-reactivity
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Evaluation of Allergen Immunotherapy
Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies  Phillip Lieberman, MD, Rima Rachid, MD 
Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model  Soichi Tofukuji, PhD, Kazufumi Katayama,
Mohamed H. Shamji, PhD, FAAAI, Stephen R. Durham, MD, FRCP 
A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS  Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit.
Reply The Journal of Allergy and Clinical Immunology: In Practice
Mechanisms of food allergy
Eric B. Brandt, PhD, Ariel Munitz, PhD, Tatyana Orekov, MS, Melissa K
Fig. 2. Putative mechanisms of oral tolerance induction in the gut
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity  James N. Francis, PhD, Louisa.
Human basophils may not undergo modulation by DC-SIGN and mannose receptor– targeting immunotherapies due to absence of receptors  Mrinmoy Das, MSc, Caroline.
TH2 adjuvants: Implications for food allergy
Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD 
Leonie Hussaarts, MSc, Luciën E. P. M
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother  Sabine Flicker, PhD, Katharina Marth, MD, Heinz.
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven.
Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization  Edwin H. Kim, MD, J. Andrew Bird, MD, Michael Kulis,
Molecular and cellular mechanisms of food allergy and food tolerance
Advances and highlights in mechanisms of allergic disease in 2015
The future of biologics: Applications for food allergy
Presentation transcript:

Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician  Philippe Moingeon, PhD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 1, Issue 3, Pages 228-241 (May 2013) DOI: 10.1016/j.jaip.2013.03.013 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 1 Allergen-specific tolerance induction via the sublingual route. The allergen(s) is (are) captured and processed by oral APCs (LCs, MDCs; macrophages) within 15 to 30 minutes. Those APCs loaded with allergen-derived peptides reach cervical lymph nodes within 12 to 24 hours, where they interact with naive CD4+ T cells to induce TH1 and Treg cells with suppressive activity within 2 to 5 days. These CD4+ T cells subsequently migrate into the blood and to tissues, resulting in long-term allergen-specific tolerance. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 228-241DOI: (10.1016/j.jaip.2013.03.013) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 2 Lack of systemic allergen exposure after sublingual administration. Mice received a ragweed pollen extract either intravenously (IV), subcutaneously (SC), or sublingually (SL). The 40 to 45-kDa Amb a 1 allergen was detected in the serum after 1, 5, 10, 20, 60 minutes with the use of a specific polyclonal rabbit antiserum. Sera from naive animals were used as controls (C). This experiment and others performed in dogs with the use of recombinant Bet v 1 confirmed the absence of detectable systemic exposure of proteins/allergens administered sublingually. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 228-241DOI: (10.1016/j.jaip.2013.03.013) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 3 Immune changes induced during SLIT. Immune changes include (1) the polarization of allergen-specific CD4+ T-cell responses, with a switch from TH2 to TH1 and Treg-cell profiles, (2) a progressive decrease in specific IgEs and rapid and sustained induction of IgG4s and IgAs, including potential blocking (ie, anti-inflammatory) antibodies, and (3) molecular alterations at the level of innate cells, including basophils and monocytes/monocyte-derived DCs. Immune mechanisms associated with SLIT and SCIT are thought to be similar, with a critical role of the induction of TH1 (immunodeviation) and Treg-cell responses (immunosuppression). The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 228-241DOI: (10.1016/j.jaip.2013.03.013) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions